BioNetwork West 2015 (past event)
October 26 - 28, 2015
Contact Us: 1.888.482.6012
Joshua Grass
Senior Vice President of Corporate and Business Development
BioMarin Pharmaceutical Inc
Check out the incredible speaker line-up to see who will be joining Joshua.
Download The Latest AgendaInnovative Dealmaking
Friday, February 10th, 2017
09:00 Therapeutic Focus Area Ice Breaker Roundtables
Get to know others with similar interests as you. Choose the therapeutic area at the top of your partnership priorities. You'll sit with 10 - 20 others seeking similar opportunities to debate the advantages and challenges assocatied with your chosen area, and start making connections!
#1 Neurodegenerative Diseases
Ilan Zipkin, Senior Investment Director, Takeda Ventures
#2 Rare Disease
Joshua A. Grass, SVP, Business and Corporate Development, BioMarin Pharmaceutical
#3 Biosimilars Across Therapeutic Areas
Michael Bayewitch, Director, Search & Evaluation, Biologics, Teva Pharmaceuticals
#4 Immunology
Kia Motesharei, Head, Global Licensing & Business Development, Immunology, EMD Serono
#5 Gene Therapy
John McDonald, VP Business Development and Mergers & Acquisitions, Biogen
#6 Oncology
Michael Attar, Executive Director, Business Development, Celgene Corporation
#7 Other (Free Flow Table)
#1 Neurodegenerative Diseases
Ilan Zipkin, Senior Investment Director, Takeda Ventures
#2 Rare Disease
Joshua A. Grass, SVP, Business and Corporate Development, BioMarin Pharmaceutical
#3 Biosimilars Across Therapeutic Areas
Michael Bayewitch, Director, Search & Evaluation, Biologics, Teva Pharmaceuticals
#4 Immunology
Kia Motesharei, Head, Global Licensing & Business Development, Immunology, EMD Serono
#5 Gene Therapy
John McDonald, VP Business Development and Mergers & Acquisitions, Biogen
#6 Oncology
Michael Attar, Executive Director, Business Development, Celgene Corporation
#7 Other (Free Flow Table)